Ephedrine hydrochloride - DE Pharmaceuticals
DE Pharmaceuticals
Description
A non-specific adrenoceptor agonist.
By mouth for reversible airway obstruction
• Adult: 15–60 mg, three times daily
By intranasal administration for nasal congestion and sinusitis affecting the maxillary atrum
• Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
• Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.
Indications
For the management of reversible airways obstruction.
Ephedrine is less suitable and less safe for use as a bronchodilator than the selective beta2 agonists, because it is more likely to cause arrhythmias and other side-effects. It should be avoided if possible.
Contraindications
Avoid use in the case of renal impairment, pregnancy and breast feeding.
Preparations Available
Tablet
Sizes Available
Tablets
15 mg, pack of 28
30 mg, pack of 28
More on: Bronchodilators , Other adrenoceptor agonists